Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001091489 | SCV001247564 | likely benign | not provided | 2019-07-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001523748 | SCV001733518 | benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2023-07-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002339394 | SCV002644700 | benign | Cardiovascular phenotype | 2021-12-16 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV001091489 | SCV001931919 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001091489 | SCV001972891 | likely benign | not provided | no assertion criteria provided | clinical testing |